fashion -WSS

fashion

author：Wikipedia 2025-09-29 22:47:51 - browse：376

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： In medicine, common shorthands can shortchange care

WSS

In medicine, common shorthands can shortchange care

'The Exorcist' director William Friedkin dead at 87

France's anti

At least 12 people were injured in a blast at a port in northwest Turkey

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

Blinken talks high

focus

fashion

explore

Alkermes shareholders re

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Alkermes shareholders re

Britney Spears to release memoir, 'The Woman In Me,' later this year

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Digital health funding stays low as a new reality sets in

Apple is now the first public company to be valued at $3 trillion

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Duchenne breakthrough therapy leaves behind pioneering families

'The Exorcist' director William Friedkin dead at 87

focus

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Trump Jan. 6 attorney John Lauro is ex

Moderna hits safety problems in bold bid to reinvent medicine

At least 12 people were injured in a blast at a port in northwest Turkey

Democratic lawmaker calls for 'well

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

focus

focus

hotspot

explore